Shanghai HeartCare Medical Technology (HKSE:06609) Other Financing: HK$0.2 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
78 GF Score
Price HK$48.24
GF Value HK$54.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shanghai HeartCare Medical Technology Other Financing?

Shanghai HeartCare Medical Technology HKSE:06609 -4.29% 78 Other Financing is HK$0.2 Mil as of Dec. 2025. GuruFocus rates HKSE:06609 with a GF Score™ of 78/100 and a GF Value™ of HK$54.80 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Shanghai HeartCare Medical Technology's Other Financing for the six months ended in Dec. 2025 was HK$-0.1 Mil.

Shanghai HeartCare Medical Technology's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.2 Mil.

Shanghai HeartCare Medical Technology Other Financing Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology Other Financing Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial -128.07 -5.90 0.29 -0.29 0.23

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 -0.04 -0.25 0.33 -0.10
HKSE:06609
78GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai HeartCare Medical Technology Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$0.2 Mil mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a Other Financing of HK$0.2 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shanghai HeartCare Medical Technology and its competitors.
Is Shanghai HeartCare Medical Technology's Other Financing too high?
Shanghai HeartCare Medical Technology's current Other Financing is HK$0.2 Mil. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's Other Financing compare to ABT and SYK?
Shanghai HeartCare Medical Technology's Other Financing of HK$0.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shanghai HeartCare Medical Technology and its competitors. Shanghai HeartCare Medical Technology's current Other Financing is HK$0.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.80, compared to a current price of HK$48.24 — trading 12% below its estimated fair value. The current Other Financing is HK$0.2 Mil. Shanghai HeartCare Medical Technology's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current Other Financing is HK$0.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$48.24 is trading 12% below its estimated GF Value™ of HK$54.80. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • Other Financing: HK$0.2 Mil
  • GF Value™: HK$54.80 vs. price of HK$48.24 (12% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
78GF Score

Get the complete analysis for HKSE:06609

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$48.24
Price
HK$54.80
GF Value